Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2004
10/13/2004EP1011752B1 Cell processing system and method for controlling it
10/13/2004EP1004303B1 Composition having capability of removing risk factor during exercise
10/13/2004EP0719147B1 Gene therapy for solid tumors, papillomas and warts
10/13/2004EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
10/13/2004CN1537161A Antigen presenting cells, method for their preparation and their use for cancer vaccines
10/13/2004CN1536075A Method for inducing bone marrow mesenchymal stem cells to differentiate into insulin-like cells
10/13/2004CN1535972A New compound,its preparation method, medicine preparation using said compound as active component, its action and application
10/13/2004CN1535734A Production process of raw material bovine blood for preparing bacteriphage-less low-endotoxin bovine serum
10/13/2004CN1535722A Colostrum peptide and its application
10/13/2004CN1535697A Preparation of lactobacillin dispersion tablet and its preparation method
10/13/2004CN1535696A Chinese medicine for resisting virus
10/13/2004CN1535695A Locust form making method and antifatigue application of its powder
10/13/2004CN1535694A Chinese medicine for curing tumor and its production method
10/13/2004CN1535625A Stomach-fortifying beverage and its preparation method
10/13/2004CN1535601A Vedvet deerhorn areca nut
10/13/2004CN1170575C Exterio-applied medical wine for treating trauma
10/13/2004CN1170570C Detoxicating ointment for treating burn and scald and its preparing process
10/13/2004CN1170566C Externally applied pain-reliveing plaster and its prepn
10/13/2004CN1170565C Cancer treating astringent medicine decoction
10/13/2004CN1170564C Virus eliminating medicine
10/13/2004CN1170563C Blood pressure stabilizing pill
10/13/2004CN1170556C Chinese medicine for treating neoplasm
10/13/2004CN1170555C Chinese patent medicine for treating ulcer diseases
10/13/2004CN1170554C Help producing saliva and slaking thirst traditional Chinese medicine powder
10/13/2004CN1170553C Medicinal wine for treating rheumatic and rheumatoid diseases
10/13/2004CN1170547C No-stinking fish-oil composite micro-capsule and preparation process
10/13/2004CN1170511C Compositions for freezing dog sperm and method for employing the frozen dog sperm
10/12/2004US6803454 Method for extraction and purification of cartilage type proteoglycan
10/12/2004US6803211 Cancer therapy
10/12/2004US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same
10/12/2004US6803192 B7-H1, a novel immunoregulatory molecule
10/12/2004US6803056 Herpes virus; topical applying propolis
10/12/2004US6803036 Treating peripheral blood mononuclear cells from donor with transforming growth factor beta, interleukin-2 and at least one other t cell activator; allogenic bone marrow transplants
10/12/2004US6803035 Administering an egg product to the animal suffering from the diarrhea, and the egg product is obtained from a hyperimmunized avian with an immunogenic or genetic vaccine
10/12/2004US6802982 Blood processing systems and methods using red blood cell hematocrit as a process control parameter
10/07/2004WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof
10/07/2004WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof
10/07/2004WO2004085632A1 Control of stem cell differentiation induction and differentiation potency
10/07/2004WO2004085630A1 Perivascular mesenchymal precursor cells
10/07/2004WO2004085628A1 Lactic acid utilising bacteria and their therapeutic use
10/07/2004WO2004084967A1 Blood vessel-specific organogenesis from embryonic stem cells on three-dimensional matrigel layer
10/07/2004WO2004084950A2 Cell targeting methods and compositions
10/07/2004WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
10/07/2004WO2004084927A2 Compositions for inducing of immunotolerance
10/07/2004WO2004084925A1 Ointment for joining broken and fractured bones
10/07/2004WO2004084923A1 Antistress agent
10/07/2004WO2004084922A1 Infection inhibitor for fishes and shellfishes
10/07/2004WO2004084921A1 Perivascular mesenchymal precursor cell induced blood vessel formation
10/07/2004WO2004084828A2 Keratinocyte-fibrocyte concomitant grafting for wound healing
10/07/2004WO2004084825A2 Wound healing composition derived from low platelet concentration plasma
10/07/2004WO2004073728A3 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
10/07/2004WO2004062677A9 Bacteriophage for the treatment of bacterial biofilms
10/07/2004WO2004046319A3 Bacteriophage having modified holin and uses thereof
10/07/2004WO2002092000A3 Hbm variants that modulate bone mass and lipid levels
10/07/2004WO2002088317A3 Fusion molecules and methods for treatment of immune diseases
10/07/2004US20040199935 Cytoplasmic transfer to de-differentiate recipient cells
10/07/2004US20040198769 Composition (RUCD) for protecting and/or repairing DNA from oxidative damages and a method thereof
10/07/2004US20040198689 Ribozyme sequences related to hiv resistance
10/07/2004US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs
10/07/2004US20040197908 Using cartilage differentiation inducing broth, undifferentiated mesenchymal cells and ultrasonic pulsation to induce, differentiate and propagate bone tissue; treating bone disorders
10/07/2004US20040197902 Transgenic mammalian endothelial progenitor cells for use in the treatment of vision defects; gene therapy and neovascularization
10/07/2004US20040197900 Generating dopaminergic neurons by contacting neuroprogenitor cells with transcription elongation factor, foggy, for treatment of drug addiction, nervous system, behavioral and sexual disorders
10/07/2004US20040197891 Isolating plasmin, in presence of fibrinogen, from blood or bodily fluids by contacting mixture with chromatographic support comprised of rigidily fixed tranexamic acid or 4-aminomethylbicyclo-[2.2.2.]-octane-1-carboxylic acid
10/07/2004US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy
10/07/2004US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering
10/07/2004US20040197790 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
10/07/2004US20040197374 Implantable pouch seeded with insulin-producing cells to treat diabetes
10/07/2004US20040197373 Composition for filling bone defects
10/07/2004US20040197352 Microencapsulaed or enteric coated; therapy for kidney disease; health of gastrointestinal system; probiotic bacteria which reduces creatine or organonitrogen compound
10/07/2004US20040197351 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine
10/07/2004US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/07/2004US20040197342 Swine plasma albumin; gene expression of immunostimulant; prevent infections; anticancer agents
10/07/2004US20040197339 Deer blood serum containing Borella and antibody thereof
10/07/2004US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins
10/07/2004US20040197319 Wound healing composition derived from low platelet concentration plasma
10/07/2004US20040197317 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
10/07/2004US20040197311 Device for regeneration of articular cartilage and other tissue
10/07/2004US20040197310 Therapy for circulation diseases; administering stem cells solution directly into heart
10/07/2004US20040197309 Schwann cells originating in myeloid interstitial cells
10/07/2004US20040197308 Dna which controls gene expression; insertion of gene into tumor cells
10/07/2004US20040195710 Generating biocompatible microspheres; obtain macromolecule solution, mix biocompatible particles, form geometric shapes, expose shape to radiation, recover microspheres
10/07/2004DE19943488B4 Mittel zur Behandlung von Tauben Agents for treating pigeons
10/07/2004DE10313284A1 Vascularized tissue substitute useful for repairing tumor-induced defects in the mouth, jaw and facial region comprises microparticles colonized by stroma cells together with endothelial cells in a fibrin matrix
10/07/2004DE10311889A1 Zellpräparat und Verwendung des Präparats zur Behandlung von Gelenken und Knorpeldefekten, sowie Verfahren zur Herstellung Cell preparation and use of the preparation for the treatment of joints and cartilage defects, and methods for preparing
10/07/2004DE10311620A1 Knorpelzell-Kulturmedium und Verwendung desselben The same cartilage cell culture medium and use
10/07/2004CA2816489A1 Perivascular mesenchymal precursor cells
10/07/2004CA2520445A1 Induction of differentiation of stem cells, and control of differentiation potency of stem cells
10/07/2004CA2520390A1 Perivascular mesenchymal precursor cell induced blood vessel formation
10/07/2004CA2520273A1 Perivascular mesenchymal precursor cells
10/07/2004CA2519204A1 Lactic acid utilising bacteria and their therapeutic use
10/07/2004CA2518793A1 Methods of inducing immunotolerance and compositions for use therein
10/06/2004EP1464697A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
10/06/2004EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
10/06/2004EP1463803A2 Hematopoietic cells from human embryonic stem cells
10/06/2004EP1463801A2 Transdifferentiation of pancreatic acinar cells
10/06/2004EP1463800A2 Chondrocyte precursors derived from human embryonic stem cells
10/06/2004EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004EP1463798A2 Islet cells from human embryonic stem cells
10/06/2004EP1463797A2 Methods of kidney transplantation utilizing developing nephric tissue
10/06/2004EP1463757A2 Antisense compounds directed against human csf-1